Lamivir HBV Tablet (Lamivudine 100mg)

What is Lamivir HBV Tablet (Lamivudine 100mg)?

Lamivir HBV Tablet contains lamivudine, a nucleoside reverse transcriptase inhibitor (NRTI), approved for the treatment of chronic hepatitis B virus (HBV) infection. It works by slowing the reproduction of the virus in the body, helping to reduce liver inflammation and prevent disease progression. This medication is taken orally, typically once daily, and is intended for long-term use in adults and select pediatric patients as prescribed by a healthcare provider.

Key features

• Active Ingredient — Lamivudine 100mg per tablet for effective HBV suppression.
• Antiviral Action — Inhibits HBV replication by targeting viral DNA synthesis.
• Oral Dosage Form — Convenient tablet for daily administration.
• Liver Protection — Helps reduce risk of cirrhosis and liver damage over time.
• Trusted Formulation — Manufactured under strict quality standards for consistency.
• Prescription-Based — Designed for use under medical supervision.
• Stable Storage — No refrigeration needed; store at room temperature.

Who is Lamivir HBV Tablet (Lamivudine 100mg) for?

This tablet is intended for individuals diagnosed with chronic hepatitis B infection, particularly those showing evidence of active viral replication and liver inflammation. It may be prescribed to adults and children over a certain weight threshold, depending on physician assessment. It is not a cure but helps manage the condition and improve long-term liver health.

How does Lamivir HBV Tablet (Lamivudine 100mg) compare?

Compared to newer antivirals like tenofovir, lamivudine has a longer safety record but a higher risk of drug resistance with prolonged use. It is less potent than modern alternatives but remains a cost-effective option in certain treatment plans. Unlike combination HIV-HBV therapies, Lamivir HBV is specifically dosed for hepatitis B monoinfection, making it suitable for patients not co-infected with HIV.